XT
OBIO icon

XTX Topco’s Orchestra BioMed OBIO Stock Holding History

XTX Topco’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$167K Buy
+38,814
New +$159K ﹤0.01% 3335
2026
Q1 		– Sell
-50,358
Closed -$209K – 4208
2025
Q4 		$209K Buy
50,358
+15,540
+45% +$62.7K 0.01% 2367
2025
Q3 		$86.3K Buy
34,818
+18,001
+107% +$49.7K ﹤0.01% 2060
2025
Q2 		$45.1K Buy
+16,817
New +$49.1K ﹤0.01% 2031

Other funds holding OBIO

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

XTX Topco's OBIO Position: Q2 2026 in Review

XTX Topco opened a new position in Orchestra BioMed (OBIO) in Q2 2026: 38,814 shares worth $167K. The stake represents ﹤0.01% of the portfolio and ranks #3335 among its holdings. This is a return to the name: XTX Topco previously reported a position in OBIO as recently as Q4 2025.

XTX Topco first reported a position in OBIO in Q2 2025 and has held it in 4 quarters since. The position peaked at $209K in Q4 2025. 77 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

  • XTX Topco held 38,814 shares of Orchestra BioMed worth $167K as of Q2 2026.
  • Orchestra BioMed was a new XTX Topco position in Q2 2026.
  • Orchestra BioMed made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3335 holding.
  • XTX Topco first reported a position in Orchestra BioMed in Q2 2025 and has held it in 4 quarters since.
  • XTX Topco's Orchestra BioMed position peaked at $209K in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.